This inventor holds 1 USPTO granted patent. Top assignee: Knoll Aktiengesellschaft. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: The Innovations of Peter Dresen
Introduction
Peter Dresen is a notable inventor based in Viernheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approaches to drug formulation. His work has led to the development of a unique drug delivery system that enhances the efficacy of medications.
Latest Patents
One of Peter Dresen's key patents is the "Alginate-based verapamil-containing depot drug form." This invention describes an alginate-based depot drug form that allows for precise adjustment of the release rate of the active substance in vitro. This innovation has the potential to improve patient outcomes by providing more controlled drug delivery.
Career Highlights
Peter Dresen is associated with Knoll Aktiengesellschaft, a company known for its advancements in pharmaceutical research and development. His work at the company has been instrumental in pushing the boundaries of drug formulation and delivery systems.
Collaborations
Throughout his career, Peter has collaborated with esteemed colleagues such as Heinz Einig and Evamarie Balz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Peter Dresen's contributions to the field of pharmaceuticals, particularly through his patented alginate-based drug form, highlight his role as a significant inventor. His work continues to influence the development of more effective drug delivery systems.